The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Prevalence and Predictors of Risk for Type 2 Diabetes Mellitus and Impaired Glucose Tolerance in Polycystic Ovary Syndrome: A Prospective, Controlled Study in 254 Affected Women
Open accessAbstract
Women with polycystic ovary syndrome (PCOS) are insulin resistant, have insulin secretory defects, and are at high risk for glucose intolerance. We performed this study to determine the prevalence of glucose intolerance and parameters associated with risk for this in PCOS women. Two-hundred and fifty-four PCOS women, aged 14-44 yr, were prospectively evaluated at 2 centers, 1 urban and ethnically diverse (n = 110) and 1 rural and ethnically homogeneous (n = 144). The rural PCOS women were compared to 80 control women of similar weight, ethnicity, and age. A 75-g oral glucose challenge was administered after a 3-day 300-g carbohydrate diet and an overnight fast with 0 and 2 h blood samples for glucose levels. Diabetes was categorized according to WHO criteria. The prevalence of glucose intolerance was 31.1% impaired glucose intolerance (IGT) and 7.5% diabetes. In nonobese PCOS women (body mass index, <27 kg/m2), 10.3% IGT and 1.5% diabetes were found. The prevalence of glucose intolerance was significantly higher in PCOS vs. control women (chi2 = 7.0; P = 0.01; odds ratio = 2.76; 95% confidence interval = 1.23-6.57). Variables most associated with postchallenge glucose levels were fasting glucose levels (P < 0.0001), PCOS status (P = 0.002), waist/hip ratio (P = 0.01), and body mass index (P = 0.021). The American Diabetes Association criteria applied to fasting glucose significantly underdiagnosed diabetes compared to the WHO criteria (3.2% vs. 7.5%; chi2 = 4.7; P = 0.046; odds ratio = 2.48; 95% confidence interval = 1.01-6.69). We conclude that 1) PCOS women are at significantly increased risk for IGT and type 2 diabetes mellitus at all weights and at a young age; 2) these prevalence rates are similar in 2 different populations of PCOS women, suggesting that PCOS may be a more important risk factor than ethnicity or race for glucose intolerance in young women; and 3) the American Diabetes Association diabetes diagnostic criteria failed to detect a significant number of PCOS women with diabetes by postchallenge glucose values.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As such, women with PCOS exhibit increased risk of impaired glucose tolerance and T2DM regardless of weight and age [20].”
From Exercise, or exercise and diet for the management of polycystic ovary syndrome: a systematic review and meta-analysis (2019) · cites this paper as [20]
In the citing paper
“Approximately 50–70% of women with PCOS have IR and hyperinsulinaemia [128], whereas many also present evidence of glucose intolerance [20].”
From Exercise, or exercise and diet for the management of polycystic ovary syndrome: a systematic review and meta-analysis (2019) · cites this paper as [20]
In the citing paper
“In women with PCOS, dysglycemia typically consists of impaired glucose tolerance [12], its prevalence being of almost 30% in both adult women [13] and affected adolescents [14].”
From From Prediabetes to Type 2 Diabetes Mellitus in Women with Polycystic Ovary Syndrome: Lifestyle and Pharmacological Management (2020) · cites this paper as [12]
In the citing paper
“PCOS patients commonly have metabolic complications, such as type 2 diabetes, insulin resistance (IR), and adipose tissue dysfunction (7–9).”
From Circulating Adipokine Levels in Nonobese Women with Polycystic Ovary Syndrome and in Nonobese Control Women: A Systematic Review and Meta-Analysis (2021) · cites this paper as [7]
In the citing paper
“However, women with PCOS generally have hyperandrogenism and lower SHBG [52] and differences at the end of the intervention are again likely related to baseline differences.”
From Weight management interventions in women with and without PCOS: a systematic review (2017) · cites this paper as [52]
In the citing paper
“However, women with PCOS generally have hyperandrogenism and lower SHBG [52] and differences at the end of the intervention are again likely related to baseline differences.”
From Weight management interventions in women with and without PCOS: a systematic review (2017) · cites this paper as [52]
In the citing paper
“In PCOS, other novel CVD risk factors, premature cardiovascular dysfunction and subclinical CVD 29,30,83 have been noted and are related to IR and obesity. 84-89”
From Assessment and management of polycystic ovary syndrome: Summary of an evidence-based guideline (2011) · cites this paper as [85]
Citations
Cites
The publisher hasn’t deposited this paper’s reference list.
Cited by
Sorted by citations
Items 501–600 of 1,388
Legro, R. S., Roller, R. L., Dodson, W. C., Stetter, C. M., Kunselman, A. R., & Dunaif, A. E. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1849 · Cited by 54
Self-citationFlorakis, D., Diamanti‐Kandarakis, E., Katsikis, I., Nassis, G. P., Karkanaki, A., Georgopoulos, N. A., & Panidis, D. (2007) · International Journal of Obesity · doi:10.1038/sj.ijo.0803777 · Cited by 53
Menstrual Disorders and Menstrual Hygiene Practices in Higher Secondary School Girls
Nair, M. K. C., Chacko, D., Darwin, M. R., Padma, K., George, B., & Russell, P. S. (2011) · The Indian Journal of Pediatrics · doi:10.1007/s12098-011-0431-z · Cited by 55
Talbott, E. O., Zborowski, J. V., Rager, J. R., Kip, K. E., Xu, X., & Orchard, T. J. (2007) · Journal of Women s Health · doi:10.1089/jwh.2006.0098 · Cited by 56
Cibula, D. (2002) · Human Reproduction · doi:10.1093/humrep/17.1.76 · Cited by 53
Serum adiponectin and lipid concentrations in pregnant women with polycystic ovary syndrome
Sir‐Petermann, T., Echiburú, B., Maliqueo, M. A., Crisosto, N., Sanchez, F., Hitschfeld, C., Cárcamo, M., Amigo, P., & Pérez‐Bravo, F. (2007) · Human Reproduction · doi:10.1093/humrep/dem090 · Cited by 55
Lamb, J. D., Johnstone, E. B., Rousseau, J.-A., Jones, C. L., Pasch, L. A., Cedars, M. I., & Huddleston, H. G. (2011) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2010.12.006 · Cited by 59
Guzick, D. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1136 · Cited by 53
Nada, S. E., Thompson, R. C., & Padmanabhan, V. (2010) · Endocrinology · doi:10.1210/en.2010-0666 · Cited by 54
Rice, S., Pellatt, L. J., Bryan, S., Whitehead, S. A., & Mason, H. D. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2060 · Cited by 54
Current perspectives of insulin resistance and polycystic ovary syndrome
Pauli, J. M., Raja-Khan, N. T., Wu, X., & Legro, R. S. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03460.x · Cited by 55
Self-citationCaanen, M. R., Schouten, N. E., Kuijper, E. A. M., van Rijswijk, J., van den Berg, M. H., Broeder, E. V. D., Overbeek, A., van Leeuwen, F. E., van Trotsenburg, M., & Lambalk, C. B. (2017) · Human Reproduction · doi:10.1093/humrep/dex098 · Cited by 54
The role of the endogenous opioid system in polycystic ovary syndrome
Eyvazzadeh, A. D., Pennington, K. P., Pop‐Busui, R., Sowers, M., Zubieta, J., & Smith, Y. R. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.05.012 · Cited by 54
Sex differences in the effects of androgens acting in the central nervous system on metabolism
Morford, J. J., & Mauvais‐Jarvis, F. (2016) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2016.18.4/fmauvais · Cited by 53
Zhang, N., Shi, Y., Hao, C., Gu, H. F., Li, Y., Zhao, Y., Wang, L., & Chen, Z. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0576 · Cited by 54
Kaur, R., Kaur, T., & Kaur, A. (2018) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-018-1162-0 · Cited by 54
Hudecova, M., Holte, J., Olovsson, M., Larsson, A. O., Berne, C., & Poromaa, I. S. (2011) · Human Reproduction · doi:10.1093/humrep/der065 · Cited by 53
Diabetes Prevalence and Risk Factors in Polycystic Ovary Syndrome
Legro, R. S. (2001) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(05)70188-1 · Cited by 53
Self-citationLewandowski, K. C., Skowrońska‐Jóźwiak, E., Łukasiak, K., Gałuszko, K., Dukowicz, A., Cedro, M., & Lewiñski, A. (2019) · Archives of Medical Science · doi:10.5114/aoms.2019.82672 · Cited by 55
Romanowski, M. D., Parolin, M. B., de Freitas, A. C. T., Piazza, M. J., BASSO, J., & Urbanetz, A. A. (2015) · Arquivos de Gastroenterologia · doi:10.1590/s0004-28032015000200008 · Cited by 53
A novel single nucleotide polymorphism of INSR gene for polycystic ovary syndrome
Lee, E.-J., Oh, B., Lee, J., Kimm, K., Lee, S., & Baek, K. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.05.026 · Cited by 54
Rajkhowa, M., Brett, S., Cuthbertson, D. J., Lipina, C., Ruiz‐Alcaraz, A. J., Thomas, G. E., Logie, L., Petrie, J. R., & Sutherland, C. D. (2008) · Biochemical Journal · doi:10.1042/bj20082176 · Cited by 56
The adipose cell lineage is not intrinsically insulin resistant in polycystic ovary syndrome
Corbould, A. M., & Dunaif, A. E. (2007) · Metabolism · doi:10.1016/j.metabol.2006.12.021 · Cited by 52
Self-citationMetabolic abnormalities in adolescents with polycystic ovary syndrome in south china
Huang, J., Ni, R., Chen, X., Huang, L., Mo, Y., & Yang, D. (2010) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-8-142 · Cited by 52
Greenwood, E. A., Noel, M., Kao, C., Shinkai, K., Pasch, L. A., Cedars, M. I., & Huddleston, H. G. (2015) · Fertility and Sterility · doi:10.1016/j.fertnstert.2015.10.020 · Cited by 59
Pathak, G., & Nichter, M. (2015) · Social Science & Medicine · doi:10.1016/j.socscimed.2015.10.007 · Cited by 52
The clinical significance of anti-Müllerian hormone evaluation in gynecological endocrinology
Karkanaki, A., Vosnakis, C., & Panidis, D. (2011) · HORMONES · doi:10.14310/horm.2002.1299 · Cited by 52
Chinese herbal medicine for subfertile women with polycystic ovarian syndrome
Zhou, K., Zhang, J., Xu, L., Wu, T., & Lim, C. E. D. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007535.pub3 · Cited by 61
Dokras, A., Jagasia, D. H., Maifeld, M., Sinkey, C. A., Voorhis, B. J. V., & Haynes, W. G. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.05.038 · Cited by 52
DHEA-Mediated Inhibition of the Pentose Phosphate Pathway Alters Oocyte Lipid Metabolism in Mice
Jimenez, P. T., Frolova, A. I., Chi, M. M.-Y., Grindler, N. M., Willcockson, A. R., Reynolds, K. A., Zhao, Q., & Moley, K. H. (2013) · Endocrinology · doi:10.1210/en.2012-2140 · Cited by 53
Hahn, S., Backhaus, M., Broecker‐Preuss, M., Tan, S., Dietz, T., Kimmig, R., Schmidt, M., Mann, K., & Janssen, O. E. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0143 · Cited by 51
Lee, H., Oh, J. Y., Sung, Y., Chung, H., & Cho, W. Y. (2009) · Endocrine · doi:10.1007/s12020-009-9226-7 · Cited by 55
Seow, K., Juan, C., Hsu, Y.-P., Ho, L., Wang, Y.-Y., & Hwang, J. (2004) · Human Reproduction · doi:10.1093/humrep/deh589 · Cited by 52
Current perspectives in polycystic ovary syndrome.
Richardson, M. R. (2003) · PubMed · Cited by 51
Use of metformin in the treatment of polycystic ovary syndrome
Genazzani, A. D., Ricchieri, F., & Lanzoni, C. (2010) · Women's Health · doi:10.2217/whe.10.43 · Cited by 51
Vitamin D in polycystic ovary syndrome: Relationship to obesity and insulin resistance
Joham, A. E., Teede, H. J., Cassar, S., Stepto, N. K., Strauss, B. J., Harrison, C. L., Boyle, J. A., & de Courten, B. V. (2015) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500259 · Cited by 51
Imbalanced circulating matrix metalloproteinases in polycystic ovary syndrome
Gomes, V. A., Vieira, C. S., Jacob‐Ferreira, A. L., Belo, V. D. A., Soares, G. M., Fernandes, J. B. F., Ferriani, R. A., & Tanus-Santos, J. E. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-0793-6 · Cited by 51
Echiburú, B., Pérez‐Bravo, F., Maliqueo, M. A., Sánchez, F., Crisosto, N., & Sir‐Petermann, T. (2008) · Metabolism · doi:10.1016/j.metabol.2008.08.002 · Cited by 51
Polycystic Ovarian Syndrome and the Metabolic Syndrome
Sartor, B. M., & Dickey, R. P. (2005) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200512000-00012 · Cited by 50
Saleh, A., & Khalil, H. S. (2004) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/j.0001-6349.2004.00481.x · Cited by 54
Marcondes, J. A. M., Hayashida, S. A. Y., Barcellos, C. R. G., Rocha, M. P., Maciel, G. A. R., & Baracat, E. C. (2007) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302007000600012 · Cited by 51
Tang, T. H., Lord, J. M., Norman, R. J., Yasmin, E., & Balen, A. H. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003053.pub3 · Cited by 51
Cianci, A., Panella, M. M., Fichera, M., Falduzzi, C., Bartolo, M., & Caruso, S. (2015) · Gynecological Endocrinology · doi:10.3109/09513590.2015.1014784 · Cited by 51
Identification of subjects with polycystic ovary syndrome using electronic health records
Castro, V., Shen, Y., Yu, S., Finan, S., Pau, C. T., Gainer, V., Keefe, C. C., Savova, G., Murphy, S. N., Cai, T., et al. (2015) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-015-0115-z · Cited by 51
Ressler, I. B., Grayson, B. E., Ulrich‐Lai, Y. M., & Seeley, R. J. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00182.2014 · Cited by 51
Polycystic Ovary Syndrome in Adolescents
Mastorakos, G. P., Lambrinoudaki, I. V., & Creatsas, G. K. (2006) · Pediatric Drugs · doi:10.2165/00148581-200608050-00004 · Cited by 51
Polycystic Ovary Syndrome and Its Differential Diagnosis
Lane, D. E. (2006) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000197817.93201.04 · Cited by 51
Evidence for pancreatic β-cell dysfunction in brothers of women with polycystic ovary syndrome
Sam, S., Sung, Y., Legro, R. S., & Dunaif, A. E. (2007) · Metabolism · doi:10.1016/j.metabol.2007.08.010 · Cited by 48
Self-citationWongwananuruk, T., Rattanachaiyanont, M., Leerasiri, P., Indhavivadhana, S., Techatraisak, K., Angsuwathana, S., Tanmahasamut, P., & Dangrat, C. (2012) · International Journal of Endocrinology · doi:10.1155/2012/571035 · Cited by 53
Optical quality of the diabetic eye: a review
Calvo‐Maroto, A. M., Pérez-Cambrodí, R. J., Albarán-Diego, C., Pons, A., & Cerviño, A. (2014) · Eye · doi:10.1038/eye.2014.176 · Cited by 52
Lefebvre, T., Dumont, A., Pigny, P., & Dewailly, D. (2017) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2017.05.013 · Cited by 49
Yılmaz, B., Vellanki, P., Ata, B., & Yıldız, B. O. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.04.024 · Cited by 53
Moll, E., Korevaar, J. C., Bossuyt, P. M., & van der Veen, F. (2008) · Human Reproduction · doi:10.1093/humrep/den182 · Cited by 48
Long-term metabolic, cardiovascular and neoplastic risks with polycystic ovary syndrome
Cattrall, F. R., & Healy, D. L. (2004) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2004.05.005 · Cited by 50
Li, R., Yu, G., Yang, D., Li, S., Lu, S., Wu, X., Wei, Z., Song, X., Wang, X., Fu, S., et al. (2014) · BMC Endocrine Disorders · doi:10.1186/1472-6823-14-76 · Cited by 50
Reproductive Health as a Sentinel of Chronic Disease in Women
Rich-Edwards, J. W. (2009) · Women s Health · doi:10.2217/17455057.5.2.101 · Cited by 50
Ouyang, P., WENGER, N. K., Taylor, D. A., Rich-Edwards, J. W., Steiner, M. S., Shaw, L. J., Berga, S. L., Miller, V. M., & Merz, C. N. B. (2016) · Biology of Sex Differences · doi:10.1186/s13293-016-0073-y · Cited by 54
Metabolic Syndrome in Polycystic Ovary Syndrome
Pasquali, R. (2018) · Frontiers of hormone research · doi:10.1159/000485995 · Cited by 49
Prediction of Insulin Sensitivity in Nonobese Women with Polycystic Ovary Syndrome
Cibula, D., Škrha, J., Hill, M., Fanta, M., Haaková, L., Vrbíková, J., & Zivny, J. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020586 · Cited by 50
Sharma, S. T., Wickham, E. P., & Nestler, J. E. (2007) · Endocrine Practice · doi:10.4158/ep.13.4.373 · Cited by 49
Öner, G., & Müderris, İ. İ. (2011) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2011.07.005 · Cited by 51
Pau, C. T., Keefe, C. C., Duran, J. M., & Welt, C. K. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-4021 · Cited by 50
The relationship between polycystic ovary syndrome, glucose tolerance status and serum preptin level
Bu, Z., Kuok, K., Meng, J., Wang, R., Xu, B., & Zhang, H. (2012) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-10-10 · Cited by 49
Molecular Mysteries of Polycystic Ovary Syndrome
Strauss, J. F., & Dunaif, A. E. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.6.0285 · Cited by 47
Self-citationNestler, J. E. (2002) · Human Reproduction · doi:10.1093/humrep/17.8.1950 · Cited by 50
Bahçeci, M., Aydemır, M., & Tuzcu, A. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.11.031 · Cited by 49
Çakal, E., Üstün, Y., Üstün, Y. E., Özkaya, M., & Kılınç, M. (2010) · Gynecological Endocrinology · doi:10.3109/09513590.2010.501874 · Cited by 49
Sepilian, V., Crochet, J. R., & Nagamani, M. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.10.038 · Cited by 49
Yun, J.-H., Choi, J.-W., Lee, K.-J., Shin, J.-S., & Baek, K. (2011) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-9-131 · Cited by 48
Ferjan, S., Janež, A., & Jensterle, M. (2017) · Endocrine Practice · doi:10.4158/ep-2017-0027 · Cited by 50
Patil, K., Hinduja, I. N., & Mukherjee, S. (2020) · Human Reproduction · doi:10.1093/humrep/deaa351 · Cited by 48
Fertility in Polycystic Ovary Syndrome
Patel, S. M., & Nestler, J. E. (2006) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2005.09.005 · Cited by 48
Polycystic Ovary Syndrome and the Metabolic Syndrome
Sharpless, J. L. (2003) · Clinical Diabetes · doi:10.2337/diaclin.21.4.154 · Cited by 49
Prenatal programming: adverse cardiac programming by gestational testosterone excess
Vyas, A. K., Hoang, V., Padmanabhan, V., Gilbreath, E., & Mietelka, K. A. (2016) · Scientific Reports · doi:10.1038/srep28335 · Cited by 48
Çağlar, G. S., Öztaş, E., Karadağ, D., Pabuçcu, R., & Demırtaş, S. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.06.092 · Cited by 48
Chatterjee, B., Suri, J., Suri, J. C., Mittal, P., & Adhikari, T. (2014) · Sleep Medicine · doi:10.1016/j.sleep.2014.06.023 · Cited by 47
Diagnosis and treatment of polycystic ovarian syndrome in adolescents
Nicandri, K. F., & Hoeger, K. M. (2012) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e32835a1a03 · Cited by 49
Polycystic Ovary Syndrome, Depression, and Affective Disorders
Bishop, S. C., Basch, S., & Futterweit, W. (2009) · Endocrine Practice · doi:10.4158/ep09083.rar · Cited by 47
High-visfatin levels in women with polycystic ovary syndrome: evidence from a meta-analysis
Sun, Y., Wu, Z., Wei, L. S., Liu, C., Zhu, S., & Tang, S. (2015) · Gynecological Endocrinology · doi:10.3109/09513590.2015.1056140 · Cited by 47
Balen, A. H. (2008) · CRC Press eBooks · doi:10.3109/9781439807224 · Cited by 48
Lee, E.-J., Yoo, K., Kim, S.-J., Lee, S., Cha, K., & Baek, K. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.12.073 · Cited by 47
Androgens in Health and Disease
Bagatell, C. J., & Bremner, W. J. (2003) · Humana Press eBooks · doi:10.1385/1592593887 · Cited by 56
Hurd, W. W., Abdel-Rahman, M. Y., Ismail, S. A., Abdellah, M. A., Schmotzer, C. L., & Sood, A. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.07.002 · Cited by 46
Bhattacharya, K., Sengupta, P., Dutta, S., Chaudhuri, P., Das Mukhopadhyay, L., & Syamal, A. K. (2021) · Endocrine · doi:10.1007/s12020-020-02555-3 · Cited by 45
Pregnancy outcomes in women with polycystic ovarian syndrome
D’Alterio, M. N., Sigilli, M., Succu, A. G., GHISU, V., Laganà, A. S., Sorrentino, F., Nappi, L., Tinelli, R., & Angioni, S. L. (2021) · Minerva Obstetrics and Gynecology · doi:10.23736/s2724-606x.21.04758-4 · Cited by 50
Obstructive sleep apnea and metabolic dysfunction in polycystic ovary syndrome
Nitsche, K., & Ehrmann, D. A. (2010) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2010.08.001 · Cited by 48
The prevalence of Type 2 diabetes is not increased in normal-weight women with PCOS
Pelanis, R., Mellembakken, J. R., Poromaa, I. S., Ravn, P., Morin-Papunen, L. C., Tapanainen, J. S., Piltonen, T., Puurunen, J., Hirschberg, A. L., Fedorcsák, P., et al. (2017) · Human Reproduction · doi:10.1093/humrep/dex294 · Cited by 46
Manti, M., Fornes, R., Pironti, G., Haworth, S. M., Zhuge, Z., Benrick, A., Carlström, M., Andersson, D. C., & Stener‐Victorin, E. (2019) · Cardiovascular Research · doi:10.1093/cvr/cvz180 · Cited by 47
Cardiovascular Risk Factors in Healthy Women with Previous Gestational Hypertension
Paradisi, G., Biaggi, A., Savone, R., Ianniello, F., Tomei, C., Caforio, L., & Caruso, A. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1337 · Cited by 46
Lindholm, Å., Bixo, M., Björn, I., Wölner‐Hanssen, P., Eliasson, M., Larsson, A. O., Johnson, O., & Poromaa, I. S. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.05.002 · Cited by 47
Kolbus, A., Walch, K., Nagele, F., Wenzl, R. J., Unfried, G., & Huber, J. C. (2006) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2006.08.002 · Cited by 46
Eagleson, C. A., Bellows, A. B., Hu, K., Gingrich, M. B., & Marshall, J. C. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030167 · Cited by 46
Elting, M. W., Korsen, T. J. M., & Schoemaker, J. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01412.x · Cited by 46
Cardiometabolic Features of Polycystic Ovary Syndrome: Role of Androgens
Cardozo, L. L. Y., Romero, D. G., & Reckelhoff, J. F. (2017) · Physiology · doi:10.1152/physiol.00030.2016 · Cited by 48
Zhong, Z., Li, F., Li, Y., Qin, S., Wen, C., Fu, Y., & Xiao, Q. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.8463 · Cited by 46
RetractedEndocrine Disruptors, Obesity, and Cytokines - How Relevant Are They to PCOS?
Šimková, M., Vítků, J., Kolátorová, L., Vrbíková, J., Vosátková, M., Včelák, J., & Dušková, M. (2020) · Physiological Research · doi:10.33549/physiolres.934521 · Cited by 53
Insulin resistance, insulin sensitization and inflammation in polycystic ovarian syndrome.
Dhindsa, G., Bhatia, R., Dhindsa, M., & Bhatia, V. (2004) · PubMed · Cited by 48
Toscani, M. K., Mario, F. M., Radavelli-Bagatini, S., & Spritzer, P. M. (2011) · Nutrition Research · doi:10.1016/j.nutres.2011.01.009 · Cited by 47
Sung, Y., Oh, J. Y., Chung, H., & Lee, H. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.11.027 · Cited by 45
Metadata
- Authors
- Legro, R. S.
- Affiliations
- Pennsylvania State University (US)
- ORCID
- Legro, R. S.
- Venue
- Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1999-01-01
- Volume
- 84
- Issue
- 1
- Pages
- 165-169
- ISSN
- 0021-972X (ISSN-L)
- OpenAlex
- W2096126402
- Cited by
- 1,743
- References
- 0
- Citations by year
- 2026: 16 · 2025: 25 · 2024: 36 · 2023: 24 · 2022: 50 · 2021: 64 · 2020: 54 · 2019: 42 · 2018: 43 · 2017: 66 · 2016: 59 · 2015: 88 · 2014: 81 · 2013: 73 · 2012: 84
- FWCI
- 44.44
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion, cc-by)
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK040605)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (K08 HD-O118, U54HD034449)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Keywords
- polycystic ovary syndrome, type 2 diabetes, impaired glucose tolerance, insulin resistance, insulin secretion, diabetes risk factors, prevalence, fasting blood glucose, waist-to-hip ratio, body mass index, ethnic differences, diagnostic criteria, underdiagnosis, oral glucose tolerance test, young women, obesity
- MeSH terms
- Adolescent, Adult, Blood Glucose, Diabetes Mellitus, Type 2, Female, Glucose Tolerance Test, Humans, Insulin Resistance, Polycystic Ovary Syndrome, Prospective Studies, Risk, Body Mass Index, Prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
